Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (1): 30-34.doi: 10.3736/jcim20100106

• Original Clinical Research • Previous Articles     Next Articles

Relationship between quality of life and basic syndromes of traditional Chinese medicine in patients with posthepatitic cirrhosis

 Qin Zhanga, Lei Wanga, Ping Liub   

  1. a Department of Liver Diseases, Shanghai Public Clinical Health Center, Fudan University, Shanghai 201508, China
    b Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2009-07-27 Accepted:2009-10-15 Online:2010-01-20 Published:2010-01-15
  • Contact: Ping Liu E-mail:liuping@shutcm.com

Objective

To investigate the main factors influencing the quality of life and the relationship between quality of life and basic syndromes of traditional Chinese medicine (TCM) in patients with posthepatitic cirrhosis.
Methods

The outcomes of revised Short Form-36 Health Survey (SF-36) Questionnaire in 108 patients with posthepatitic cirrhosis and the normal control population were assessed, and the related clinical information including gender, age, body mass index (BMI), course of disease, basic syndromes of disease and main laboratory parameters were collected. The data were analyzed by t-test, analysis of variance (ANOVA) and stepwise regression analysis.
Results

The Cronbach’s α coefficient of the revised SF-36 questionnaire was 0.773, indicating good consistency within the items. The outcomes of revised SF-36 and the scores of physical function, role physical, bodily pain, mental health, and social function in the patients with posthepatitic cirrhosis were significantly lower than those in the normal control population (P<0.01). Correlation analysis showed that there was a correlation between basic TCM syndromes and scores of physical function, mental health, role emotion, vitality, and general health. Stepwise regression analysis indicated that basic TCM syndromes, aspartate aminotransferase, total billirubin, albumin, and prothrombin time played major role in the quality of life in the patients with posthepatitic cirrhosis, and the values of regression coefficient were 0.262, –0.297 8, –0.483 9, –0.483 9, –0.512 3, –0.571 9 respectively.
Conclusion

The quality of life in the patients with posthepatitic cirrhosis is significantly decreased. The revised SF-36 with basic TCM syndrome items is more objective and has certain clinical practical value on measurement of quality of life in patients with posthepatitic cirrhosis.

Key words: Hepatitis, Liver cirrhosis, Quality of life, Syndrome, Traditional Chinese medicine

Table 1

Values of quality of life in normal control population and patients with posthepatitic cirrhosis ($\bar{x}$±s)"

Evaluation item Normal control (n=100) Posthepatitic cirrhosis (n=108)
Physical function 83.32±9.61 71.53±10.24**
Role physical 90.62±8.91 62.72±20.34**
Bodily pain 70.30±11.23 69.72±9.09**
General health 71.25±10.63 55.18±9.35**
Vitality 50.12±30.29 49.04±9.25
Social function 80.12±11.11 51.18±9.45**
Role emotion 69.36±21.30 68.93±11.50
Mental health 76.13±16.21 50.96±7.87**
Factors of TCM syndrome 80.10±22.43 45.66±13.68**
SF-36 77.49±8.76 60.41±9.29**

Table 2

Correlation analysis of the items of SF-36 in patients with posthepatitic cirrhosis"

Evaluation items Physical
function
Role
physical
Mental
health
Role
emotion
Social
function
Vitality Bodily
pain
General
health
Factors of
TCM syndrome
Physical function 1
Role physical 0.231 4 1
Bodily pain 0.325 6 0.102 2 1
General health 0.224 3 0.438 7 0.374 5 1
Vitality 0.252 3 0.375 6 0.268 9 0.297 4 1
Social function 0.563 4 0.391 5 0.684 2 0.512 1 0.396 8 1
Role emotion 0.238 9 0.192 8 0.402 3 0.287 9 0.201 3 0.445 2 1
Mental health 0.513 9 0.321 5 0.381 3 0.331 1 0.321 4 0.506 6 0.236 5 1
Factors of TCM syndrome 0.631 1 0.453 2 0.697 8 0.603 1 0.521 4 0.711 3 0.451 3 0.692 7 1

Table 3

Main factors influencing quality of life in patients with posthepatitic cirrhosis"

Screened factor Regression coefficient Standard error F P
Factors of TCM syndrome 0.256 2 0.054 3 4.820 0.024 7
AST –0.297 8 0.235 9 3.931 0.022 3
TB –0.483 9 0.127 6 2.865 0.031 1
Alb –0.512 3 0.049 7 2.636 0.036 0
PT –0.5719 0.215 3 2.043 0.045 1
[1] Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J . Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B[J]. J Chin Integr Med, 2003,1(2):89-98, 102
doi: 10.3969/j.issn.1008-861X.2002.01.013
刘平, 胡义扬, 刘成, 徐列明, 刘成海, 孙克伟, 胡德昌, 尹有宽, 周霞秋, 万谟彬, 蔡雄, 张志清, 叶军, 唐宝璋, 贺佳 . 扶正化瘀胶囊干预慢性乙型肝炎肝纤维化作用的多中心临床研究[J]. 中西医结合学报, 2003,1(2):89-98, 102
doi: 10.3969/j.issn.1008-861X.2002.01.013
[2] Zhang Q, Liu P, Zhang HW, Wang L, Du GL, Chen HF, Chen L, Wang JR, Wang XB . Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2006,26(8):694-697
doi: 10.7661/CJIM.2006.8.694
张琴, 刘平, 章浩伟, 王磊, 都广礼, 陈慧芬, 陈良, 王江容, 王宪波 . 900例肝炎后肝硬化中医证候判别模式的研究[J]. 中国中西医结合杂志, 2006,26(8):694-697
doi: 10.7661/CJIM.2006.8.694
[3] Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association. Prevention and treatment program for viral hepatitis[J]. Zhonghua Gan Zang Bing Za Zhi, 2000,8(6):324-329
中华医学会传染病与寄生虫学会、肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志, 2000,8(6):324-329
[4] Lin XL, You LM, Ma YY, Yan J . A study on living quality and related factors of hepatitis B patients with hepatocirrhosis[J]. Hu Li Yan Jiu, 2006,20(2):304-305
doi: 10.3969/j.issn.1009-6493.2006.04.009
林晓岚, 尤黎明, 马盈盈, 颜君 . 乙型病毒性肝炎后肝硬化病人生存质量及相关因素的研究[J]. 护理研究, 2006,20(2):304-305
doi: 10.3969/j.issn.1009-6493.2006.04.009
[5] Li WW, Li Q, Wang JB, Li XY, Zhang LX, An Y, Zhang QG . Factors associated with health-related quality of life in patients with liver cirrhosis[J]. Shandong Da Xue Xue Bao Yi Xue Ban, 2006,44(9):885-888
doi: 10.3969/j.issn.1671-7554.2006.09.007
李雯雯, 李强, 王晶波, 李晓迎, 张立新, 安勇, 张琴冈 . 乙肝肝硬化患者生活质量相关因素分析[J]. 山东大学学报(医学版), 2006,44(9):885-888
doi: 10.3969/j.issn.1671-7554.2006.09.007
[6] Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD . Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan[J]. World J Gastroenteol, 2005,11(47):7494-7498
doi: 10.3748/wjg.v11.i47.7494
[7] Park CK, Park SY, Kim ES, Park JH, Hyun DW, Yun YM, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YH, Park SG . Assessment of quality of life and associated factor in patients with chronic viral liver disease[J]. Taehan Kan Hakhoe Chi, 2003,9(3):212
[1] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[2] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[3] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[4] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[5] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[6] Rebecca Kulbida, Alexander Mathes, Johannes Loeser. Beneficial effects of hirudotherapy in a chronic case of complex regional pain syndrome. Journal of Integrative Medicine, 2019, 17(5): 383-386.
[7] Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[8] Charles Dalcanale Tesser, Ari Ojeda Ocampo Moré, Melissa Costa Santos, Emiliana Domingues Cunha da Silva, Fátima Terezinha Pelachini Farias, Lúcio José Botelho. Auriculotherapy in primary health care: A large-scale educational experience in Brazil. Journal of Integrative Medicine, 2019, 17(4): 302-309.
[9] Rachael Farrington, Ian F.Musgrave, Roger W.Byard. Evidence for the efficacy and safety of herbal weight loss preparations. Journal of Integrative Medicine, 2019, 17(2): 87-92.
[10] Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
[11] Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.
[12] Goulnar Kasymjanova, Anh-Thi Tran, Victor Cohen, Carmela Pepe, Lama Sakr, David Small, Jason Scott Agulnik, Robert Thomas Jagoe. The use of a standardized Chinese herbal formula in patients with advanced lung cancer: A feasibility study. Journal of Integrative Medicine, 2018, 16(6): 390-395.
[13] Mehranghiz Ebrahimi-Mameghani, Mohammad Asghari-Jafarabadi, Khatereh Rezazadeh. TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2018, 16(5): 329-334.
[14] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[15] Ching-Feng Su. Home care with acupuncture increased the quality of life in a patient with advanced cancer with neuropathic pain induced by bone metastasis: A case report. Journal of Integrative Medicine, 2018, 16(3): 208-210.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[5] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[6] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[7] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[8] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[9] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022